In other cancers, Guo et al. found that MSI2 expression was markedly increased in both pancreatic ductal adenocarcinoma (PDAC) cell lines and human PDAC specimens, and high MSI2 expression was associated with poor prognosis of PDAC [48]. This evidence concerns the gene MSI2 and pancreatic ductal adenocarcinoma.